Genmab — Februar 2021
-
Duoblo. Der er vist ikke meget at kommentere udover at der tages gevinst og risiko ud af markedet. Det går ud over mange aktier.
-
Det kan være det bliver en Porsche i morgen kl. 9.00
-
@Pensionisten-Måske må du nøjes med en Trabi..:-D
-
-
Guidance ser ud til at ligge til den skuffende side
-
Måske det er voldgiften, der er taget ud af toplinien?
-
Revenue 6800-7500m
-
Operating restult dkk 1000-2000m for 2021
-
Dara guides til DARZALEX
royalties of DKK 4,900 – 5,300 million. -
GEN skriver selv om voldgiften ifht guidance: Given the ongoing arbitration, Genmab has reflected this as a reduction to estimated 2021 revenue.
-
Der er skåret i toplinjen...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind